US OptionsDetailed Quotes
SPOT241213C492500
- 0.13
- -0.42-76.36%
15min DelayClose Dec 13 16:00 ET
0.55High0.13Low
0.55Open0.55Pre Close3 Volume214 Open Interest492.50Strike Price81.00Turnover829.68%IV1.93%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.13Extrinsic Value100Contract SizeAmericanOptions Type0.0537Delta0.0190Gamma3717.77Leverage Ratio-399.5109Theta0.0000Rho199.59Eff Leverage0.0008Vega
Spotify Technology Stock Discussion
Sign in to post a comment
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 ...
+2
9
1
4
$Spotify Technology (SPOT.US)$ fking surprised at how the fuck is this valued. 100 billion? lmfao
1
$Spotify Technology (SPOT.US)$ this beast is going to fly
$Spotify Technology (SPOT.US)$ Another monster this year 😱
No comment yet
10xStockPicks OP : This is the correctly edited research report. Previous article has a few typos. Special thanks to Fund manager John for his notes. Please do your own research. I firmly believe ESPR will be a solid bet.